2026 Workshop Programme

Altered neuroplasticity is now recognised as a central mechanism in both mood disorders and neurodegenerative disease — driven largely by chronic neuroinflammation and dysregulated microglial activity. This presentation explores how BDNF signalling and neurotrophic support link these conditions, and introduces the first RCT demonstrating that a novel bioavailable herbal combination achieved clinically meaningful reductions in depression scores in patients with inadequate antidepressant response. Cutting-edge neuroscience, translated into practical clinical strategies.